Status:

TERMINATED

Effect of a Low Glycemic Index Diet on Breast Density

Lead Sponsor:

Roswell Park Cancer Institute

Conditions:

Breast Cancer

Eligibility:

FEMALE

40-60 years

Phase:

NA

Brief Summary

This study is a Pilot Phase II cancer intervention trial of a low glycemic index diet to reduce mammographic density in women at high risk for breast cancer.

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Are between 40 and 60 years of age
  • Still menstruating with at least 10 menstrual cycles in the previous 12 months
  • Not Taking hormone replacement therapy
  • Stable oral contraceptive use (no changes is use in past 12 months nor changes intended during interventional period)
  • Have not been previously diagnosed with breast cancer, DCIS,lobular carcinoma in situ, atypical lobular hyperplasia or atypical hyperplasia
  • No history of breast augmentation or reduction surgery
  • Have no history of any other malignancy (excluding non-melanoma skin cancer) in the previous 5 years
  • Have no history of diabetes or other metabolic diseases requiring dietary modification
  • Have a study baseline mammographic density of at least 50% as estimated by mammographer
  • BIRADS 1 or 2 mammogram if first ever mammogram, otherwise stable mammogram (no change since previous year)
  • Have not followed a weight reduction or Atkins typs diet in the past 6 months Not pregnant or lactating in the past 12 months, nor intending pregnancy during the study period
  • Successful completion of three baseline telephone-administered 24- hour dietary recalls

Exclusion

    Key Trial Info

    Start Date :

    March 1 2006

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    Estimated Enrollment :

    46 Patients enrolled

    Trial Details

    Trial ID

    NCT01237938

    Start Date

    March 1 2006

    Last Update

    April 3 2014

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Roswell Park Cancer Institute

    Buffalo, New York, United States, 14263